Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: May 2016

Rutgers Cancer Institute of NJ Researcher Explores Gender Disparity in Lung Cancer

Sharad Goyal, MD

Sharad Goyal, MD

New Brunswick, May 31, 2016 ― Lung cancer is the leading cause of cancer death in both men and women. Lung cancer diagnoses have more than doubled among females in the past 38 years, while having fallen 29 percent among males, according to the American Lung Association.

Aiming to better understand gender differences in this disease, Rutgers Cancer Institute of New Jersey radiation oncologist Sharad Goyal, MD, is embarking on new research supported by an inaugural $400,000 LUNG FORCE Research Innovation Project: Lung Cancer in Women Award from the American Lung Association.

The work will explore whether radiation exposure from interventional cardiovascular procedures leads to increased risk of lung cancer in women as compared to men. Continue reading

U.S. Patient’s Infection Raises Specter of Superbugs Resistant to All Antibiotics

Superbug definitionNew York, NY, May 31, 2016 ― Sabrina Tavernise and Denise Grady reported in The New York Times that American military researchers have identified the first patient in the United States to be infected with bacteria that are resistant to an antibiotic that was the last resort against drug-resistant germs.

The patient is well now, but the case raises the specter of superbugs that could cause untreatable infections, because the bacteria can easily transmit their resistance to other germs that are already resistant to additional antibiotics.

The resistance can spread because it arises from loose genetic material that bacteria typically share with one another. Continue reading

Biotechnology Innovation Organization Releases Largest Study Ever on Clinical Development Success Rates

BIO Logo New NameWashington, DC, May 30, 2016Biotechnology Innovation Organization (BIO) on May 25 released the largest ever study of clinical development success rates.  The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies.

Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success.

“This study provides a wealth of information about drug development success rates across a broad range of indications,” said Cartier Esham, PhD, BIO’s Executive Vice President, Emerging Companies. Continue reading

HINJ Portal Highlights Member Companies’ Corporate Social Responsibility and Sustainability Activities

CSR chasing arrowsNew Brunswick, NJ, May 29, 2016 ― The HealthCare Institute of New Jersey (HINJ) has updated its online portal to HINJ member companies’ myriad corporate social responsibility (CSR) activities, including their corporate philanthropy, patient outreach initiatives and sustainability/green practices.

Launched in November 2014 and promoted via Twitter, Facebook and LinkedIn, HINJ’s CSR online portal has become one of the most-visited areas of the association’s website.

The portal — “HINJ Members’ CSR Activities” — is accessible by clicking on the second tab under the HINJ homepage’s Corporate Social Responsibility menu. Continue reading

Vice President Biden Claims ‘Total Bipartisan Support’ for‘Moonshot’ Cancer Research Funding

Vice President Joe Biden

Vice President Joe Biden

Washington, DC, May 28, 2016 ― Vice President Biden on Thursday hinted that key GOP leaders are willing to support his billion-dollar request for cancer research funding this year, reports Sarah Ferris in The Hill.

Biden declared Thursday “there’s total bipartisan support” on Capitol Hill for his ambitious moonshot campaign to accelerate cures for cancer.

“Some of the best leadership coming from the Hill now, in terms of funding of this first year of a new moonshot, is being led by Republicans,” Biden told a roundtable at Memorial Sloan Kettering Cancer Center. Those Republicans, Biden said, “are talking about meeting my request for a billion dollars.” Continue reading

Rutgers and Dartmouth Researchers: Pursuing the Destruction of HIV-infected Cells

HIV AIDS research wordsNew Brunswick, May 27, 2016 ― Dory Devlin at Rutgers University reports that an oral drug used to treat an illness unrelated to HIV eradicated infectious HIV-producing cells in lab cultures while sparing uninfected cells — and suppressed the virus in patients during treatment and for at least eight weeks after the drug was stopped, according to results of a clinical pilot trial and researchers at Rutgers University and Dartmouth College.

The findings, published May 18 in the scientific journal PLOS ONE, point to development of a promising HIV treatment that could destroy the HIV DNA harbored in HIV-infected cells.  Current HIV-AIDS treatments center on antiretroviral drugs that, when taken in combination for all of a patient’s life, can prevent the growth of the virus but not kill or cure it. Continue reading

NJBIA: New Partnership to Foster Innovation in NJ Receives Approval of Assembly Higher Education Committee

Innovation Ahead signTrenton, NJ, May 26 2016 ― The New Jersey Business & Industry Association (NJBIA) reported that a new partnership to foster innovation in New Jersey received the approval of the Assembly Higher Education Committee last week.

A-1668, which establishes the New Jersey Commission on Higher Education and Business Partnerships, would promote innovation by helping businesses and academia work more closely together.

NJBIA supported the bill, which was first introduced last session in the Senate, now S-354.

The commission would bring together leaders in academia, business and state government to identify and stimulate academic-business collaborations to advance economic development and employment. Continue reading

Governor Christie’s Investment in Charter Schools Yields Invaluable Return in Student Performance

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, May 25, 2016 ― Governor Chris Christie on May 18 visited Bergen Arts and Sciences Charter School (BASCS) in Hackensack, highlighting the type of successful classrooms and challenging curriculum that his administration is working to replicate in public schools and new charter schools across New Jersey.

“BASCS is a model public school, offering children opportunities to excel as budding experts in high-demand fields,” Governor Christie said.  “This is the kind of accountable and challenging learning environment that New Jersey’s successful charter schools are providing students in every ZIP code.”

“Charter schools like BASCS are ensuring America will remain a powerhouse, particularly when it comes to developing and executing cutting-edge technologies and other critical STEM-related careers,” Governor Christie said. Continue reading

Christie Administration Announces Zika Virus Testing in New Jersey

Zika VirusTrenton, NJ, May 24, 2016 ― The New Jersey Public Health and Environmental Laboratories (PHEL) began testing blood samples late last week for Zika, dengue and chikungunya viruses, all caused by mosquito-transmitted viruses and found in a number of countries worldwide.

The New Jersey Public Health and Environmental Laboratories (PHEL), located on the grounds of the State Police headquarters in West Trenton, is among a select group of state and local public health labs outside the federal Centers for Disease Control and Prevention (CDC) that is prepared to test for Zika.

“The ability to test residents for Zika and similar viruses will further enhance New Jersey’s preparedness and response to this evolving health emergency unfolding in the Caribbean and Central and South Americas,” Acting Health Commissioner Cathleen Bennett said.  “We continue working every day to prevent local transmission as mosquito season approaches in New Jersey.” Continue reading

Fairleigh Dickinson University Names Dr. Gillian Small University Provost and Senior Vice President for Academic Affairs

Fairleigh Dickinson SquareTeaneck, NJ, May 24, 2016 ― Fairleigh Dickinson University has named Gillian Small University Provost and Senior Vice President for Academic Affairs, making her the University’s second ranking officer.  Her appointment will begin August 1, 2016.

“Dr. Small’s depth of experiences, her many strengths and talents and her passion for advancing and building successful initiatives make her an ideal choice for this critical position,” said University President Sheldon Drucker.

President-elect Christopher A. Capuano added that, “Small has a well-established history of building collaborative opportunities both across CUNY as well as with external partners. She will be a great champion for FDU’s academic programs and progress.” Continue reading